Congo Begins Ebola Vaccinations for Health Workers.
Congo on Saturday started vaccinating health workers in Bunia against Ebola. The city is the epicenter of what authorities describe as the fastest-growing Ebola outbreak in history.
- 7,541 confirmed cases and 3,639 deaths recorded as of Saturday, per government figures.
- 20,000 front-line workers are targeted across Ituri and North Kivu over six to nine months.
- 70,000 Ervebo doses approved for Congo; 50,000 for workers, 20,000 for a clinical trial.
- The WHO says the outbreak is on track to exceed the 2014-2016 West Africa outbreak, which killed more than 11,000.
Why it matters: Ervebo is licensed against the Zaire strain of Ebola, not the Bundibugyo virus causing this outbreak. Health authorities say the two viruses are related and the vaccine may offer some protection, but effectiveness has not been confirmed.
- The vaccine is being used under a compassionate-use program, which permits unapproved medical products in serious disease situations.
- Spread is fueled by insecurity, population displacement, a health workers' strike, and intense population movements.
How 4 sources split on this story
Center coverage, 2 sources: The center presents the outbreak and vaccination drive primarily through official figures, WHO assessments, and the AP's on-the-ground reporting.
Left coverage, 1 sources: The left covers the human dimension through named health workers expressing uncertainty and obligation about receiving an unproven vaccine.
What’s next: A clinical trial using 20,000 Ervebo doses will study protection against the Bundibugyo virus.
- The rollout expands a prior campaign that already covered 14 health zones in Tshopo, Bas-Uele, and Haut-Uele provinces.
- Does Ervebo provide meaningful protection against the Bundibugyo virus strain driving this outbreak?
- Can the vaccination campaign reach 20,000 workers on schedule given ongoing insecurity and a health workers' strike?